Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
University of Oklahoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
University of Nebraska
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Astellas Pharma Inc
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Nagoya University
Instituto do Cancer do Estado de São Paulo
University of Chicago